A
Avenue Therapeutics
ATXI
2.82500
USD
0.005
(0.18%)
مفتوح الان
حجم التداول
1,155
الربح لكل سهم
0
العائد الربحي
0
P/E
0
حجم السوق
2,848,398
الأخبار
العنوان: Avenue Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.